• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《中国食管胃交界腺癌外科治疗专家共识(2024年版)》

[Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (Edition 2024)].

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Feb 25;27(2):109-126. doi: 10.3760/cma.j.cn441530-20231212-00213.

DOI:10.3760/cma.j.cn441530-20231212-00213
PMID:38413076
Abstract

The publication of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition) has widely accelerated the standardization and homogenization on the surgical treatment of adenocarcinoma of esophagogastric junction (AEG). In China, the surgical outcomes of AEG, the universality and practicability of this consensus has also been affirmed after the clinical practice during the past 5 years. Due to the persistent increasing incidence of AEG, the specificity on anatomic site, clinicopathological characteristics, molecular biological characteristics, AEG had been always the hotspot of many clinical trials and more clinical evidences had been published. However, its definition, classification, staging, surgical approach, resection pattern, extent of lymphadenectomy, and the digestive tract reconstruction etc. remain controversial. In light of the above, it is necessary to update the 2018 edition of consensus. The Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2024 edition) is generated based on the currently available and best clinical evidence, the latest global guidelines or consensuses, and the opinions from the Chinese expert panel. The present consensus focuses on the key points of surgical treatment and issues in dispute, and provides scientific recommendations. The goal of this expert consensus was to improve the homogeneity in understanding and practice between Chinese thoracic and gastrointestinal surgeons, and to further standardize surgical treatment of AEG. Those pending issues in this consensus need high-quality clinical research to further investigate.

摘要

《中国食管胃交界腺癌外科治疗专家共识(2018版)》的发布极大地推动了食管胃交界腺癌(AEG)外科治疗的标准化和同质化。在中国,AEG的外科治疗效果以及该共识在过去5年临床实践后的通用性和实用性也得到了肯定。由于AEG的发病率持续上升,其解剖部位、临床病理特征、分子生物学特征的特殊性,AEG一直是众多临床试验的热点,也发表了更多临床证据。然而,其定义、分类、分期、手术方式、切除模式、淋巴结清扫范围以及消化道重建等仍存在争议。鉴于此,有必要更新2018版共识。《中国食管胃交界腺癌外科治疗专家共识(2024版)》是基于当前可得的最佳临床证据、最新的全球指南或共识以及中国专家小组的意见制定的。本共识聚焦于外科治疗的关键点和争议问题,并提供科学建议。本专家共识的目标是提高中国胸外科和胃肠外科医生在认识和实践上的同质性,并进一步规范AEG的外科治疗。本共识中那些悬而未决的问题需要高质量的临床研究进一步探究。

相似文献

1
[Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (Edition 2024)].《中国食管胃交界腺癌外科治疗专家共识(2024年版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Feb 25;27(2):109-126. doi: 10.3760/cma.j.cn441530-20231212-00213.
2
[Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition)].《食管胃交界腺癌外科治疗中国专家共识(2018年版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):961-975.
3
[Interpretation of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (2018 edition)].《食管胃交界腺癌外科治疗中国专家共识(2018版)》解读
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):101-106.
4
[Interpretation of Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction(2024 edition)].《食管胃交界腺癌外科治疗中国专家共识(2024年版)》解读
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Feb 25;27(2):127-131. doi: 10.3760/cma.j.cn441530-20231212-00214.
5
[Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].[经胸与经腹入路治疗食管胃交界部Siewert II型腺癌的生存比较:胸外科与胃肠外科联合数据分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):132-142.
6
[Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery].[食管胃交界部SiewertⅡ型腺癌的治疗:胸外科视角]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Feb 25;25(2):109-113. doi: 10.3760/cma.j.cn441530-20211222-00526.
7
[Surgical strategy for adenocarcinoma of esophagogastric junction].[食管胃交界腺癌的手术策略]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):107-111.
8
[Retrospect of 2019: focus on the surgical treatment for adenocarcinoma of esophagogastric junction].《2019年回顾:聚焦食管胃交界腺癌的外科治疗》
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jan 25;23(1):20-25. doi: 10.3760/cma.j.issn.1671-0274.2020.01.004.
9
[Laparoscopic proximal gastrectomy and lymph node resection in adenocarcinoma of the esophagogastric junction].[腹腔镜下食管胃交界腺癌近端胃切除术及淋巴结清扫术]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Feb 25;25(2):114-119. doi: 10.3760/cma.j.cn441530-20211103-00446.
10
[Several issues on surgical treatment for adenocarcinoma of esophagogastric junction].[食管胃交界腺癌手术治疗的若干问题]
Zhonghua Wai Ke Za Zhi. 2022 Sep 1;60(9):807-812. doi: 10.3760/cma.j.cn112139-20220417-00172.

引用本文的文献

1
Development and validation of CT-based fusion model for preoperative prediction of invasion and lymph node metastasis in adenocarcinoma of esophagogastric junction.基于CT的融合模型在食管胃交界腺癌术前侵袭和淋巴结转移预测中的开发与验证
BMC Med Imaging. 2025 Jul 1;25(1):242. doi: 10.1186/s12880-025-01777-z.
2
Effect of thoracic size on postoperative outcomes in transabdominal gastrectomy for Siewert type II/III adenocarcinoma of the esophagogastric junction.胸廓大小对经腹胃切除术治疗食管胃交界部Siewert II/III型腺癌术后结局的影响。
World J Surg Oncol. 2025 Feb 15;23(1):54. doi: 10.1186/s12957-025-03691-8.
3
Development and validation of a preoperative model for predicting positive proximal margins in adenocarcinoma of the esophagogastric junction and assessing safe margin distance.
用于预测食管胃交界腺癌近端切缘阳性及评估安全切缘距离的术前模型的开发与验证
Front Oncol. 2024 Dec 10;14:1503728. doi: 10.3389/fonc.2024.1503728. eCollection 2024.